CAR-T therapy

Pediatric Oncology CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Marina Borisevich • Volha Karas • Inna Proleskovskaya • Alexander Meleshko • Dmitry Luckovich • Volha Mishkova
doi.org/10.69690/ODMJ-018-0425-4062
Pediatric Oncology Landscape Assessment To Characterize Baseline Access And Multilevel Barriers To Improve Access To CAR-T Cell Therapy (Impact Study) Across The Euro Region
Aleksandra Oszer • Claudia Rössig • Jacques-Emmanuel Galimard • Joseph Wardell • Antonio Perez-Martinez • Jan Styczyński • Taisiya Yakimkova • Carlos Rodriguez-Galindo • Wojciech Młynarski • Asya Agulnik • Caitlyn Duffy • Krzysztof Kałwak • Kjeld Schmiegelow
doi.org/10.69690/ODMJ-018-0425-3980